Dr. Mark McClellan, a physician and economist who has served both the commissioner of the U.S. Food and Drug Administration (FDA) and administrator of the Centers for Medicare & Medicaid Services, was hired by Blackstone as a senior advisor for the firm’s private equity business lines.
He will bring his expertise across the life sciences and healthcare and public sectors to advise on the work of Blackstone Growth and Blackstone Life Sciences.
Blackstone’s private equity business saw its assets jump 40% in 2019 to a record $183 billion with inflows of $57 . . .
Continue Reading With Our Special Offer
Unlock this article instantly, along with the rest of our premium content and newsletters, with a 20% discount by using the coupon code VIDRIO2021.
Already a subscriber? Log in.